Home » Rejection of InterMune’s Drug Told Early to FDA Advisers
Rejection of InterMune’s Drug Told Early to FDA Advisers
December 27, 2012
Three members of an independent advisory panel say they received as much as a day’s notice in May 2010 before U.S. regulators rejected a drug from InterMune, now tied to an insider trading probe of SAC Capital Advisors.
Bloomberg
Bloomberg
Upcoming Events
-
21Oct